Table 1 The clinical and pathologic characteristics of the included patients
Variable | Patients (178) | CDCA5 overexpression group | Low CDCA5 expression group | Odds Ratio | P value |
|---|---|---|---|---|---|
Liver cirrhosis, n(%) | 128 (71.91) | 63 (70.79) | 65 (73.03) | 0.895 | 0.739 |
Tumor diameter, median (range) | 5.88 ± 3.83 | 6.67 ± 3.97 | 5.11 ± 2.42 | 0.890 | 0.006 |
Tumor number, (%) | Â | Â | Â | 0.624 | 0.189 |
 1 | 156 (87.64) | 82(92.13) | 74 (83.15) |  |  |
 2 | 16 (8.99) | 5 (5.62) | 11 (12.36) |  |  |
  ≥ 3 | 6 (3.37) | 2(2.25) | 4 (4.49) |  |  |
Tumor margin,< 2/≥2 cm | 45/178 | 22/67 | 23/66 | 0.942 | 0.897 |
Anatomic/nonanatomic liver resection | 73/105 | 38/51 | 35/54 | 1.105 | 0.648 |
Intraoperative blood transfusion, Yes/No | 27/151 | 15 / 74 | 12 / 77 | 1.301 | 0.531 |
Tumor capsule, complete/incomplete | 88/90 | 39 / 50 | 43 / 46 | 0.834 | 0.548 |
Microvascular invasion, present/absent | 44 / 134 | 28 / 61 | 16 / 73 | 2.094 | 0.037 |
Edmondson-Steiner Grade I / II / III / IV | 33 / 78 / 65 /2 | 12 / 37 / 38 / 2 | 21 / 41 / 27 / 0 | 0.608 | 0.089 |